Each year, Cardiovascular and Metabolic diseases (CVMD) cause millions of deaths worldwide. Despite therapeutic advances, only a limited number of treatment options are available for common heart and metabolic diseases.

Janssen has an enduring commitment to researching the prevention and treatment of cardiovascular and metabolic diseases. Our aim is to develop innovative healthcare solutions that will significantly improve the outcome for patients. We are building a comprehensive approach to diabetes care as well as cardiovascular disease.

Fast facts

• Over a period of 70 years, a typical human heart will beat more than 2.5 billion times;
• Each year Cardiovascular disease (CVD) alone causes over 4.3 million deaths in Europe;
• Overall CVD is estimated to cost the EU economy €192 billion a year.

Our solutions

Our portfolio is looking for solutions to cardiovascular and metabolic diseases.